Modeling Great Solutions
Tel Aviv, Israel· Est.
FDA‑level pharmacometrics consulting that de‑risks drug development and accelerates regulatory approval.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
FDA‑level pharmacometrics consulting that de‑risks drug development and accelerates regulatory approval.
OncologyHematologyCardiovascularImmunology
Technology Platform
Population PK/PD, PBPK, and model‑based drug development using advanced statistical and simulation tools to generate regulatory‑ready quantitative evidence.
Opportunities
Rising demand for model‑based regulatory support and expansion into emerging modalities such as gene and cell therapies.
Risk Factors
Dependence on a limited pool of senior pharmacometric expertise and increasing competition from larger consulting firms.
Competitive Landscape
Competes with firms like Certara and Simcyp, differentiating through FDA‑level insider expertise and a proven track record of regulatory successes.